Study in Patients With Asthma

Dey36 enrolled

Overview

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Asthma

Interventions

Formoterol FumarateDRUG

Eligibility

Sex: ALLMin age: 5 YearsMax age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children with a history of asthma * Written guardian approval Exclusion Criteria: * Current or recent asthma exacerbation, requiring hospitalization * History of smoking * Debilitating or systemic and/or life-threatening diseases.

Locations (12)

Research Site

Little Rock, Arkansas, United States

Research Site

Long Beach, California, United States

Research Site

Mission Viejo, California, United States

Outcomes

Primary Outcomes

Measure of lung function

Secondary Outcomes

Change in lung function, as well as vital signs

Physical Exam results, AE reporting, etc

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.